Summit Therapeutics News and Activities
Presence
Summit Therapeutics is a biotechnology company that develops new medicines for serious diseases. Its main services include drug research and clinical development for healthcare providers, patients, and pharmaceutical partners.
Summit Therapeutics products and services overview:
- Cancer therapeutics
- Drug research
- Clinical development
- Immunotherapy candidates
Revenue: ~$0 million
Employees: 140
Headquarters: Oxford, United Kingdom (UK)
Summit Therapeutics is one of the...
Summit Therapeutics is a company listed under the stock ticker SMMT (US).
Acquisition, funding and merger involving Summit Therapeutics.
- Summit Therapeutics has just announced a $500 Million fundraising (posted on October 23 2025).
- Summit Therapeutics has just announced a $500 Million fundraising (posted on October 23 2025).
Executives
View the org chart displaying its 35 main executives
Most searched biographies at Summit Therapeutics
- Bob Duggan, Chief Executive Officer and Chairman of the Board
- Maky Zanganeh, Director, Chief Executive Officer and President
- Michelle Xia, Director
Create your alert
to follow the executive moves at Summit Therapeutics.
Biotechnology
Summit Therapeutics has 2,417 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).
Popular M&A news in Biotechnology
- Zymeworks has announced the acquisition of Theravance Biopharma (posted on June 29 2026).
- Tissium has just announced a $68 Million fundraising (posted on June 29 2026).
- Oblenio Bio has just announced a $62 Million fundraising (posted on June 26 2026).
Popular contacts in Biotechnology
News
Press releases by Summit Therapeutics
- Log in or sign up to view
- https://twitter.com/intent/tweet?text=%27Promising%20Anti-Tumor%20Activity%20and%20Safety%20of%20Ivonescimab%20in%20Combination%20Therapies%20in%20CRC,%20TNBC,%20and%20HNSCC%20Featured%20at%20ESMO%202024%27&url=https://www.smmttx.com/pressrelease/promising-anti-tumor-activity-and-safety-of-ivonescimab-in-combination-therapies-in-crc-tnbc-and-hnscc-featured-at-esmo-2024/
- LinkedIn Login, Sign in | LinkedIn
- Share on WhatsApp
- Log in to Facebook
- Media Resources | summittxinc.com
- View more press releases Close
Social media about Summit Therapeutics
- Summit Therapeutics on Wikipedia, Google News & Yahoo Finance
- Summit Therapeutics on LinkedIn, X (Twitter) & YouTube
